Weill Cornell Medicine investigators have identified an early step in a cellular process that leads to inflammation in fat cells and may result in type 2 diabetes in people with obesity.This article was originally published […]
What role do circulating proteins in the blood play in determining the risk of whether a person develops type 2 diabetes? Are the effects of these proteins also associated with dietary changes?This article was originally […]
Popular weight-loss drugs known as GLP-1s could soon become more affordable for Americans. On Thursday, the Trump administration and two major drugmakers announced an agreement to drastically reduce the cost of the drugs for people […]
Sleep is a hot commodity—we want it, we need it, but most of us aren’t getting enough of it.This article was originally published on MedicalXpress.com
A group from Osaka Metropolitan University in Japan, led by graduate student Tatsushi Oura and Dr. Hiroyuki Tatekawa, found that treatment using the drug lecanemab to remove amyloid plaques in the brain does not change […]
While the exact causes of neurodegenerative brain diseases like Alzheimer’s and dementia are still largely unknown, researchers have been able to identify a key characteristic in affected brains: reduced blood flow. Building upon this foundational […]
Marathons have quickly become a popular pursuit. Hundreds of thousands of people submit ballots each year to run in some of the most prestigious races. In 2024, a record number of people crossed the finish […]
Children’s Hospital Los Angeles researchers report that physical inactivity, routine checkups, binge drinking, lack of insurance, and food insecurity were the strongest correlates of diagnosed diabetes in Southern California. National models also brought additional factors […]
New findings from the Arkansas Health Survey, the largest and most comprehensive health survey in the state’s history, reveal that 24.1% of Arkansas adults who used tobacco was well above the national average of 18%, […]
A new University of California San Diego study offers compelling evidence that glucagon-like peptide-1 (GLP-1) receptor agonists—the class of drugs behind Ozempic, Wegovy and Mounjaro, for example—may do more than regulate blood sugar and weight. […]
© 2025 SimplyWell.ca